Cargando…

Specificity and Performance of Nucleocapsid and Spike-based SARS-CoV-2 Serologic Assays

There is an urgent need for an accurate antibody test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this paper, we have developed 3 ELISA methods, trimer spike IgA, trimer spike IgG, and nucleocapsid IgG, for detecting anti-SARS-CoV-2 antibodies. We evaluated their performance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tehrani, Zahra Rikhtegaran, Saadat, Saman, Saleh, Ebtehal, Ouyang, Xin, Constantine, Niel, DeVico, Anthony L., Harris, Anthony D, Lewis, George K., Kottilil, Shyam, Sajadi, Mohammad M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418763/ https://www.ncbi.nlm.nih.gov/pubmed/32793933 http://dx.doi.org/10.1101/2020.08.05.20168476

Ejemplares similares

Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assays
por: Rikhtegaran Tehrani, Zahra, et al.
Publicado: (2020)

Long-term follow-up of elite controllers: Higher risk of complications with HCV coinfection, no association with HIV disease progression
por: Stafford, Kristen A., et al.
Publicado: (2017)

Evidence of variable human Fcγ receptor-Fc affinities across differentially-complexed IgG
por: Crowley, Andrew R., et al.
Publicado: (2023)

Human post‐infection serological response to the spike and nucleocapsid proteins of SARS‐CoV‐2
por: Xiao, Cheng, et al.
Publicado: (2020)

Near-Pan-neutralizing, Plasma Deconvoluted Antibody N49P6 Mimics Host Receptor CD4 in Its Quaternary Interactions with the HIV-1 Envelope Trimer
por: Tolbert, William D., et al.
Publicado: (2021)

Antigenic Properties of the Human Immunodeficiency Virus Envelope Glycoprotein Gp120 on Virions Bound to Target Cells
por: Mengistu, Meron, et al.
Publicado: (2015)

Conformational Masking and Receptor-Dependent Unmasking of Highly Conserved Env Epitopes Recognized by Non-Neutralizing Antibodies That Mediate Potent ADCC against HIV-1
por: Lewis, George K., et al.
Publicado: (2015)

Mucosal and Systemic Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Determined by Severity of Primary Infection
por: Sajadi, Mohammad M., et al.
Publicado: (2022)

‘Self-Protection’ of Individual CD4(+) T Cells against R5 HIV-1 Infection by the Synthesis of Anti-Viral CCR5 Ligands
por: Guan, Yongjun, et al.
Publicado: (2008)

Comparative Assessment of Sera from Individuals after S-Gene RNA-Based SARS-CoV-2 Vaccination with Spike-Protein-Based and Nucleocapsid-Based Serological Assays
por: Dörschug, Anja, et al.
Publicado: (2021)

A New Monoclonal Antibody, mAb 4A12, Identifies a Role for the Glycosaminoglycan (GAG) Binding Domain of RANTES in the Antiviral Effect against HIV-1 and Intracellular Ca(2+) Signaling
por: Burns, Jennifer M., et al.
Publicado: (1998)

Recombinant nucleocapsid protein-based IgG enzyme-linked immunosorbent assay for the serological diagnosis of SARS
por: Saijo, Masayuki, et al.
Publicado: (2005)

Conserved signatures indicate HIV-1 transmission is under strong selection and thus is not a “stochastic” process
por: Gonzalez, Mileidy, et al.
Publicado: (2017)

Concurrent Exposure of Neutralizing and Non-neutralizing Epitopes on a Single HIV-1 Envelope Structure
por: Ray, Krishanu, et al.
Publicado: (2019)

Stoichiometric Analyses of Soluble CD4 to Native-like HIV-1 Envelope by Single-Molecule Fluorescence Spectroscopy
por: Agrawal, Parul, et al.
Publicado: (2019)

Performance of the Roche/Snibe electrochemiluminescent anti-SARS-COV-2 spike assays compared to the Roche/Abbott IgG nucleocapsid and Abbott IgM spike assays
por: Lau, C.S., et al.
Publicado: (2021)

2838. Safety and Immunogenicity of a gp120-CD4 Chimeric Subunit Vaccine: A Phase 1a Randomized Controlled Trial
por: Chua, Joel V, et al.
Publicado: (2019)

Identifying CCR5 coreceptor populations permissive for HIV-1 entry and productive infection: implications for in vivo studies
por: Weichseldorfer, Matthew, et al.
Publicado: (2022)

Longitudinal clinico-serological analysis of anti-nucleocapsid and anti-receptor binding domain of spike protein antibodies against SARS-CoV-2
por: Deshpande, Gururaj Rao, et al.
Publicado: (2021)

Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity
por: Lee, Eunok, et al.
Publicado: (2021)

IgG and IgM antibody formation to spike and nucleocapsid proteins in COVID-19 characterized by multiplex immunoblot assays
por: Shah, Jyotsna, et al.
Publicado: (2021)

Simultaneous detection of the spike and nucleocapsid proteins from SARS-CoV-2 based on ultrasensitive single molecule assays
por: Cai, Qiyong, et al.
Publicado: (2021)

Antibody detection of SARS-CoV spike and nucleocapsid protein
por: Chang, Mau-Sun, et al.
Publicado: (2004)

Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2
por: Liu, Wanbing, et al.
Publicado: (2020)

CD4-Induced epitopes in HIV infection
por: DeVico, Anthony, et al.
Publicado: (2006)

Spike-based COVID-19 immunization increases antibodies to nucleocapsid antigen
por: Dobaño, Carlota, et al.
Publicado: (2022)

The WHO International Standard for COVID-19 serological tests: towards harmonization of anti-spike assays
por: Infantino, Maria, et al.
Publicado: (2021)

Nucleocapsid Annealing-Mediated Electrophoresis (NAME) Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors
por: Sosic, Alice, et al.
Publicado: (2015)

Domain-specific biochemical and serological characterization of SARS-CoV-2 nucleocapsid protein
por: Wu, Chao, et al.
Publicado: (2021)

Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assays
por: Esposito, Dominic, et al.
Publicado: (2020)

Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assays
por: Esposito, Dominic, et al.
Publicado: (2020)

Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays
por: Mehalko, Jennifer, et al.
Publicado: (2020)

Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays
por: Mehalko, Jennifer, et al.
Publicado: (2021)

A flow cytometry-based assay for serological detection of anti-spike antibodies in COVID-19 patients
por: Goh, Yun Shan, et al.
Publicado: (2021)

Identification of Conserved Epitopes in SARS-CoV-2 Spike and Nucleocapsid Protein
por: Forcelloni, Sergio, et al.
Publicado: (2021)

Application of area scaling analysis to identify natural killer cell and monocyte involvement in the GranToxiLux antibody dependent cell‐mediated cytotoxicity assay
por: Pollara, Justin, et al.
Publicado: (2018)

Use of recombinant nucleocapsid proteins for serological diagnosis of feline coronavirus infection by three immunochromatographic tests
por: Takano, Tomomi, et al.
Publicado: (2014)

The coronavirus nucleocapsid protein is ADP-ribosylated
por: Grunewald, Matthew E., et al.
Publicado: (2018)

Substitutions in Spike and Nucleocapsid proteins of SARS-CoV-2 circulating in South America
por: Franco-Muñoz, Carlos, et al.
Publicado: (2020)

Computational studies of the dynamics of SARS-CoV-2 spike, membrane, and nucleocapsid proteins
por: Dutta, Mandira, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_af7somsm5recu09tpfuk0tubcr